"We thank the editor for giving us the opportunity to respond to the points raised by Tomenson.1 Further, we would like to thank Tomenson for making publicly available parts of the so far unpublished report to the sponsors (the Titanium Dioxide Manufacturers Association, for which he provides consultancy services), including particularly the positive dose–response data for the French subcohort (reanalysed in our paper). .."

Support: Digital